Working… Menu
Trial record 98 of 382 for:    IFNA2 AND RBV AND genotype

Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1 (RibaC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01226771
Recruitment Status : Completed
First Posted : October 22, 2010
Last Update Posted : March 24, 2015
The Swedish Research Council
Roche Pharma AG
Information provided by (Responsible Party):
Göteborg University